-
Posted by
Two Blokes Apr 17 -
Filed in
Stock
-
28 views
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities for the treatment of a type of blood cancer in adults who had received at least one other therapy previously.
